- Trials with a EudraCT protocol (36)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
36 result(s) found for: Epidermis.
Displaying page 1 of 2.
| EudraCT Number: 2007-003106-99 | Sponsor Protocol Number: ELBE II-2007 | Start Date*: 2007-10-04 |
| Sponsor Name:University of Kiel, Department of Dermatology | ||
| Full Title: Pimecrolimus and Epidermal Barrier Function: Role for pimecrolimus in restoring skin barrier function and normalizing epidermal lipid content and differentiation in atopic epidermis: a randomized, ... | ||
| Medical condition: Investigative study of pathogenesis/treatment of calcineurin inhibitor vs. corticosteroid confirmatory study to prior study: Pimecrolimus and Epidermal Barrier Function, Protocol No. ELBE-2005, Eud... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-003917-17 | Sponsor Protocol Number: BAK04 | Start Date*: 2005-03-07 |
| Sponsor Name:Birken GmbH | ||
| Full Title: Treatment of actinic keratoses with Birken-Oleogel in comparison to cryotherapy and the combination of cryotherapy plus Birken-Oleogel: a randomized, monocenter study. Behandlung aktinischer Kerat... | ||
| Medical condition: Actinic keratoses. These are dysplasia of the epidermis caused by chronic UV-irradiation, that developwithout treatment in 20% of the cases into skin cancer (spinalioma). aktinische Keratosen. Die... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-000726-78 | Sponsor Protocol Number: SPD488-401 | Start Date*: 2004-12-02 |
| Sponsor Name:Shire Pharmaceuticals Group plc | ||
| Full Title: A 24 Week Randomised Double Blind Placebo Controlled Study to Evaluate the Atrophogenic Potential of Eflornithine in the Treatment of Women with Excessive Facial Hair | ||
| Medical condition: Facial Hirsutism in Women | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-004824-11 | Sponsor Protocol Number: ELBE-2005 | Start Date*: 2005-04-15 |
| Sponsor Name:Universitätshautklinik Kiel | ||
| Full Title: Role for pimecrolimus in restoring skin barrier function and normalizing epidermal lipid content and differentiation in atopic epidermis: a randomized, intra-patient, double-blind (right/left arm) ... | ||
| Medical condition: Atopic Dermatitis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004592-74 | Sponsor Protocol Number: HOLOGENE7(HTA-HG7-01) | Start Date*: 2016-06-01 |
| Sponsor Name:Holostem Terapie Avanzate s.r.l. | ||
| Full Title: PROSPECTIVE, OPEN LABEL, UNCONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF AUTOLOGOUS CULTURED EPIDERMAL GRAFTS CONTAINING EPIDERMAL STEM CELLS GENETICALLY MODIFIED WITH A GAMMA-RETR... | ||
| Medical condition: RDEB is characterized by generalized skin blistering, erosions, crusts, atrophic scarring, onychodystrophy and loss of nails, mutilating pseudosyndactyly of hands and feet, as well as oral cavity l... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-000095-17 | Sponsor Protocol Number: HOLOGENE17 | Start Date*: 2017-08-17 |
| Sponsor Name:Holostem Terapie Avanzate s.r.l. | ||
| Full Title: PROSPECTIVE, OPEN-LABEL, UNCONTROLLED CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF AUTOLOGOUS CULTURED EPIDERMAL GRAFTS CONTAINING EPIDERMAL STEM CELLS GENETICALLY MODIFIED WITH A GAMMA-RETR... | ||
| Medical condition: JEB is genetically and clinically heterogeneous characterized by mutations in COL17A1,encoding for Collagen17 protein. COLXVII is a collagenous transmembrane type II protein component of the hemide... | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: AT (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-004279-20 | Sponsor Protocol Number: TUD-OCT-AD-025 | Start Date*: 2007-11-14 |
| Sponsor Name:Technical University Dresden | ||
| Full Title: Comparison of the atrophogenic effect of hydrocortisone 1% cream and Elidel (Pimecrolimus 1% cream) assessed by Optical Coherence Tomography (OCT) and 20-MHZ ultrasound of uninvolved skin in patien... | ||
| Medical condition: patients with mild to moderate atopic dermatitis not affecting the test areas | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-005339-42 | Sponsor Protocol Number: N16HPV | Start Date*: 2016-08-30 |
| Sponsor Name:NKI-AVL | ||
| Full Title: Safety, immunogenicity and clinical response of sig-HELP-E6SH/E7SH-kdel, injected in the epidermis by DNA tattoo, in HPV16-positive vulvar intraepithelial neoplasia: a phase I/II study | ||
| Medical condition: HPV16+ usual type vulvar intraepithelial neoplasia (uVIN) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-016365-29 | Sponsor Protocol Number: bcthug09 | Start Date*: 2010-09-17 |
| Sponsor Name:MIGUEL CASARES FERNÁNDEZ-ALVÉS | ||
| Full Title: Aplicación de células madre mesenquimales obtenidas de tejido adiposo del paciente quemado, para el tratamiento de la quemadura. Application of Mesenchymal Stem Cells in the management of the burn ... | ||
| Medical condition: Tratamiento de las heridas por quemadura con ADMSC | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-006126-10 | Sponsor Protocol Number: Efalizumab in CTCL | Start Date*: 2008-11-27 |
| Sponsor Name:Charité - University Hospital Berlin | ||
| Full Title: pilot study to evaluate the efficacy of Efalizumab in patients with cutaneous t-cell lymphoma | ||
| Medical condition: The cutaneous T-cell lymphoma (also known as Sézary syndrome) is a common disorder of proliferated cells with characteristics of maligne t-lymphocytes immigrating from the cutaneous blood vessels t... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-002464-24 | Sponsor Protocol Number: ESA-13/2010 | Start Date*: 2011-07-15 |
| Sponsor Name:Dr. August Wolff GmbH & Co. KG Arzneimittel | ||
| Full Title: Clinical study to investigate the efficacy and safety of an estradiol containing cream (0.01 % estradiol) in patients with dermatoporosis | ||
| Medical condition: dermatoporosis stage I and II | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-003785-13 | Sponsor Protocol Number: KTDIIS02 | Start Date*: 2021-11-19 |
| Sponsor Name:Karolinska Universitetssjukhuset | ||
| Full Title: An investigator-initiated, open label trial to investigate efficacy of brodalumab in eczematized psoriasis (BRodalumab in Eczematized PSOriasis) | ||
| Medical condition: eczematized psoriasis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-000003-20 | Sponsor Protocol Number: MEMPSOLAR0001 | Start Date*: 2021-06-08 | |||||||||||
| Sponsor Name:Aarhus University Hospital | |||||||||||||
| Full Title: AN INVESTIGATOR INITIATED, PHASE 4, OPEN-LABEL, SINGLE-ARM, SINGLE-CENTER STUDY INVESTIGATING THE RESIDUAL DISEASE MEMORY IN PSORIASIS SKIN DURING ENSTILAR® AND NARROW-BAND ULTRAVIOLET B THERAPY. ... | |||||||||||||
| Medical condition: Psoriasis vulgaris | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-000530-37 | Sponsor Protocol Number: 24978 | Start Date*: 2004-09-16 | |||||||||||
| Sponsor Name:Serono International S.A. | |||||||||||||
| Full Title: A multicentre, randomised, double blind, placebo controlled phase III study of subcutaneously administered onercept in the initial treatment and continued treatment after extended therapy in subjec... | |||||||||||||
| Medical condition: Psoriasis is an inflammatory skin disorder that affects between 1 and 2% of the population. It is characterised by an increased proliferation of the epidermis, and presents as well-defined thickene... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: LT (Completed) LV (Completed) EE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-000897-38 | Sponsor Protocol Number: DAM/001/05 | Start Date*: 2005-05-18 | |||||||||||
| Sponsor Name:FARMACEUTICI DAMOR | |||||||||||||
| Full Title: Open-label, controlled, randomised, multicentre, parallel group clinical trial of efficacy and tolerability of Fitostimoline soaked gauzes, Fitostimoline cream and Citrizan gel in the topical... | |||||||||||||
| Medical condition: Topical treatment of second-degree superficial cutaneous burns | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-004664-23 | Sponsor Protocol Number: ST 200 DS 05-01 | Start Date*: 2006-05-25 | |||||||||||
| Sponsor Name:SIGMA-TAU | |||||||||||||
| Full Title: The role of Acetyl-L-Carnitine in Reflex Sympathetic Dystrophy RDS and in Complex Regional Pain Syndrome CRPS .Pilot clinical trial. | |||||||||||||
| Medical condition: Reflex Sympathetic Dystrophy RDS and Complex Regional Pain Syndrome CRPS . | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-002339-24 | Sponsor Protocol Number: NA | Start Date*: 2012-05-25 |
| Sponsor Name:Barts and the London NHS Trust | ||
| Full Title: Open label, single-centre study to evaluate the efficacy of the bradykinin (BK) B2 receptor antagonist, Icatibant, in the relief of symptoms resulting from moderate to severe angioedema unresponsiv... | ||
| Medical condition: Idiopathic Angioedema | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-004304-12 | Sponsor Protocol Number: 2260/2006 | Start Date*: 2007-09-25 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
| Full Title: Pilot study, randomised, open-label, monocentre, case vs control study to assess the effect of topically and parenterally Heparin administration treatment in superficial and deep second grade bu... | |||||||||||||
| Medical condition: Superficial and deep second degree burns. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2018-004397-96 | Sponsor Protocol Number: CF20112018 | Start Date*: 2019-04-09 | |||||||||||
| Sponsor Name:Merete Hædersdal | |||||||||||||
| Full Title: Impact of thermo-mechanical intervention on Protoporphyrin IX accumulation and biodistribution in normal skin following topical 5-aminolevulinic acid at high and low vehicle viscosity | |||||||||||||
| Medical condition: Healthy skin on the upper back on 3 participants in study a and 12 participants in study b. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2019-002285-12 | Sponsor Protocol Number: OJ-KDC01 | Start Date*: 2019-12-02 |
| Sponsor Name:LABORATORIO OJER PHARMA, S.L. | ||
| Full Title: An exploratory, multicenter, randomized, open-label with blind evaluation, active-controlled study to evaluate the safety and efficacy of Keramod (imiquimod 50 mg/g, Gel) compared with Aldara (imi... | ||
| Medical condition: ACTINIC QUERATOSIS, also known as solar keratosis, is a skin disease caused by chronic exposure to sunlight. It appears as scaly lesions on the skin as a result of an abnormal growth of the cells i... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
